The Board of Livzon Pharmaceutical Group Inc. announced that, on 23 January 2018, the Company received a notice from Joincare Pharmaceutical Industry Group Co. Ltd. based on the total share capital of the Company of 553,231,369 shares (comprising 363,962,601 A shares and 189,268,768 H shares) as at 31 December 2017, proposing the distribution of cash dividend of RMB 20.00 (tax inclusive) for every ten shares to all shareholders of the company. The Proposed Distribution of Cash Dividend subject to the approval of the shareholders' meeting.